These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 15718172)

  • 1. Design of therapy for advanced heart failure.
    Stevenson LW
    Eur J Heart Fail; 2005 Mar; 7(3):323-31. PubMed ID: 15718172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of advanced heart failure.
    Jessup M; Brozena S
    Cardiol Rev; 2000; 8(3):148-57. PubMed ID: 11174888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Management of advanced chronic heart failure].
    Oliva F; Macera F; Verde A; Frigerio M
    G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):112S-117S. PubMed ID: 19195318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure?
    Turley AJ; Raja SG; Salhiyyah K; Nagarajan K
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1141-6. PubMed ID: 18541605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Outpatient medical and nurse management program in patients with chronic heart failure in a large territorial area in Piedmont. Four years of follow-up].
    Conte MR; Mainardi L; Iazzolino E; Casetta M; Asteggiano R; Lai F; Lusardi R; Sasso L
    Ital Heart J Suppl; 2005 Dec; 6(12):812-20. PubMed ID: 16444925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure.
    Ritzema J; Troughton R; Melton I; Crozier I; Doughty R; Krum H; Walton A; Adamson P; Kar S; Shah PK; Richards M; Eigler NL; Whiting JS; Haas GJ; Heywood JT; Frampton CM; Abraham WT;
    Circulation; 2010 Mar; 121(9):1086-95. PubMed ID: 20176990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
    Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D;
    Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of heart failure treatment.
    Guyatt GH; Devereaux PJ
    Mt Sinai J Med; 2004 Jan; 71(1):47-54. PubMed ID: 14770250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute decompensated heart failure: best evidence and current practice.
    Mehta R; Feldman D
    Minerva Cardioangiol; 2005 Dec; 53(6):537-47. PubMed ID: 16333237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How well are chronic heart failure patients being managed?
    Fonarow GC
    Rev Cardiovasc Med; 2006; 7 Suppl 1():S3-11. PubMed ID: 16955055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adaptation of guidelines for the treatment of chronic heart failure in a specialized heart failure clinic].
    Pölzl G; Gouya G; Hügel H; Frick M; Ulmer H; Pachinger O
    Wien Klin Wochenschr; 2002 Oct; 114(19-20):833-9. PubMed ID: 12503474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
    Dulin BR; Krum H
    Curr Opin Cardiol; 2006 Jul; 21(4):393-9. PubMed ID: 16755210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How many patients with heart failure are eligible for cardiac resynchronization? Insights from two prospective cohorts.
    McAlister FA; Tu JV; Newman A; Lee DS; Kimber S; Cujec B; Armstrong PW
    Eur Heart J; 2006 Feb; 27(3):323-9. PubMed ID: 16105850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the optimal medical management of ischemic heart failure?
    Cleland JG; Alamgir F; Nikitin NP; Clark AL; Norell M
    Prog Cardiovasc Dis; 2001; 43(5):433-55. PubMed ID: 11251129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Refractory heart failure. Models of hospital, ambulatory, and home management].
    Oliva F; Alunni G
    Ital Heart J Suppl; 2002 Aug; 3(8):837-50. PubMed ID: 12407839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modern therapy of cardiac insufficiency].
    Stojsić D; Jelkić N
    Med Pregl; 1999; 52(3-5):113-24. PubMed ID: 10518395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outpatient management of pediatric heart failure.
    O'Connor MJ; Rosenthal DN; Shaddy RE
    Heart Fail Clin; 2010 Oct; 6(4):515-29, ix. PubMed ID: 20869651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of heart failure management in the elderly population.
    Cheng JW; Nayar M
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):233-49. PubMed ID: 19948300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
    Cohn JN; Tognoni G;
    N Engl J Med; 2001 Dec; 345(23):1667-75. PubMed ID: 11759645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.